Dr. Lutz is an associate professor of clinical rehabilitation medicine at Weill Medical College of Cornell University in New York and an attending physician at the Hospital for Special Surgery, also in New York.
Dr. Lutz will be responsible for advancing the company’s brtxDISC program, including preparing the company’s Investigational New Drug/Investigational Device Exemption application with the U.S. Food and Drug Administration.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
